HR Execs on the Move

RF Technologies

www.rft.com

 
RF Technologies is a leading provider of safety and security solutions for the healthcare, hospitality, and education markets, leveraging radio frequency identification (RFID) and PinPoint® real-time locating system (RTLS) technologies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.rft.com
  • 3125 N 126th St
    Brookfield, WI USA 53005
  • Phone: 800.669.9946

Executives

Name Title Contact Details
Danae Schuster
Director of Human Resources Profile
Corey Garbisch
Chief Financial Officer Profile
Bob Metzler
Vice President of Product Management and Marketing Profile
Paul Larson
Vice President Of New Product Development Profile
Bill Braden
Vice President of Customer Ownership Profile

Similar Companies

iCAD

With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.

Advanced Instrument Development Inc

Advanced Instrument Development Inc is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lab Water Purification System from Aqua Solutions

Lab Water Purification System from Aqua Solutions is a Jasper, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedOptima

MedOptima is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)